Beginning in 1715 with the opening of an apothecary shop in London, our story has always focused on innovation. From a selection of individual entrepreneurs to a global company of around 100,000 employees, we’ve developed a variety of medicines and healthcare products that form the foundations of today’s GSK.
Explore our history timeline
Innovative entrepreneurs: 1715 – 1891
The early history of GSK: how a range of entrepreneurs built the foundations of the GSK we know today.
Going global : 1892 – 1918
In this period, our legacy companies expanded globally, developing and selling new products worldwide.
Creating the GSK of today: 1950 – 1999
An exciting period of discovery: we developed the first treatment for HIV, enhanced our consumer brands and developed new treatments for asthma.
GSK today: 2000 – present
With our three global businesses of Pharmaceuticals, Vaccines and Consumer Healthcare, we aim to bring differentiated, high-quality and needed healthcare products to as many people as possible.
History in motion
30 years and counting: the fight against HIV
How to find a treatment for a disease with no idea what that disease actually is.
Why are we fighting malaria in the lab and on the ground?
Despite progress to fight malaria, millions of people continue to suffer every year. We’re helping by researching medicines and vaccines, supporting community prevention and health worker training and strengthening access to medicines.
Meet Jill, a keeper of GSK’s history
Jill Moretto is one of our heritage archivists who looks after thousands of items collected throughout GSK’s 300 year history
How we discover new vaccines
Our vaccines R&D is focused on discovering prophylactic and therapeutic vaccines to protect people against infectious diseases, cancers and chronic disorders.
Find out more about us
We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
We research and develop a broad range of innovative products in three primary areas of Pharmaceuticals, Vaccines and Consumer Healthcare